Johnson & Johnson Pharmaceutical Research and Development
Johnson & Johnson Pharmaceutical Research and Development (J&J PRD) is a division of Johnson & Johnson, a multinational corporation headquartered in New Brunswick, New Jersey. The division is responsible for the research and development of pharmaceutical products.
History[edit | edit source]
Johnson & Johnson Pharmaceutical Research and Development was established to consolidate the pharmaceutical research and development activities of Johnson & Johnson. The division has played a significant role in the development of numerous pharmaceutical products that have had a substantial impact on global health.
Research Areas[edit | edit source]
J&J PRD focuses on several key therapeutic areas, including:
Notable Products[edit | edit source]
Some of the notable products developed by J&J PRD include:
- Risperdal (risperidone) - an antipsychotic medication
- Remicade (infliximab) - a monoclonal antibody used to treat autoimmune diseases
- Stelara (ustekinumab) - a medication used to treat psoriasis and other autoimmune conditions
- Xarelto (rivaroxaban) - an anticoagulant used to prevent blood clots
Research Facilities[edit | edit source]
J&J PRD operates several research facilities around the world, including locations in:
These facilities are equipped with state-of-the-art technology and staffed by leading scientists and researchers in the pharmaceutical industry.
Collaborations and Partnerships[edit | edit source]
J&J PRD collaborates with various academic institutions, research organizations, and other pharmaceutical companies to advance the development of new therapies. These partnerships are crucial for fostering innovation and accelerating the discovery of new treatments.
Commitment to Innovation[edit | edit source]
Johnson & Johnson Pharmaceutical Research and Development is committed to innovation and improving global health. The division invests heavily in research and development to bring new and effective treatments to market.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
